group
high-dose EloraTZP group
Trial participants receiving highest dose eloralintide with 15-milligram tirzepatide
Most often with
- placeUnited States 1
- placeUK 1
- placeMilan 1
- placeIndiana 1
- placeArgentina 1
- personLora Heisler 1
- personLiana K. Billings 1
- personKen Custer 1
- personDavid Risinger 1
- personDavid Preiss 1
- personDan Skovronsky 1
- organisationUS Food and Drug Administration 1
- organisationUniversity of Oxford 1
- organisationUniversity of Aberdeen 1
- organisationNovo Nordisk 1
- organisationNovo 1